Progress in search for Aids vaccine: Final phase trials likely to begin next year
Thursday 10 June 1993
Two candidate vaccines have been identified, both of which trigger a strong immune system response over several months to more than one strain of the virus, with minimal side effects in healthy volunteers. The level of antibodies produced is similar to that seen in people infected with the live HIV virus.
The vaccines have progressed to phase two trials - the only two vaccines to have done so - in healthy high-risk volunteers. Plans to recruit thousands more healthy volunteers in the US for the third and final phase of trials are under way for 1994 and 1995.
Dr Dani Bolognesi, director of the Central Immunology Laboratory at Duke University, North Carolina, told the international Aids conference in Berlin: 'HIV vaccine development can be considered at a crossroads, and is in a position to turn a corner'. Another 20 candidate vaccines are in preliminary trials worldwide.
Reports of promising vaccines are a feature of every Aids conference, but Dr Bolognesi gave the most positive report to date.
The two vaccines, known as rgp 120MN and rgp 120 SF-2, trick the body into thinking HIV has infected it. To imitate HIV, scientists used genetic engineering techniques to recreate the outer coat of the virus. The immune system should respond by producing cells which target and destroy HIV. Refinements in the genetic engineering technique used to produce parts of the viral coat mean they now mimic the live virus much more closely than early attempts.
Three doses of rgp 120MN vaccine given over six months stimulated antibodies to three strains of the virus. Three doses of the second vaccine also produced high levels of antibodies to three different strains.
Diving in at the deep end is no excuse for shirking the style stakes
- 2 Why I'm on the brink of burning my Israeli passport
- 4 L'Oreal cuts ties with Belgium supporter Axelle Despiegelaere after hunting trip photographs
- 5 War is war: Why I stand with Israel
Ian Thorpe gay: Olympic swimmer comes out in Parkinson interview
Gaza-Israel conflict: Pro-Palestinian demonstrators take to streets of London, Paris and New York in wave of protests
Israel-Gaza conflict: ‘Sderot cinema’ image shows Israelis with popcorn and chairs 'cheering as missiles strike Palestinian targets'
Israel-Gaza conflict: Israeli air strike destroys home for the disabled killing two women residents
Israel-Gaza conflict: Israeli PM says conflict may 'continue for a long time' as hundreds of Palestinians flee their homes
Sustained immigration has not harmed Britons' employment, say government advisers
War is war: Why I stand with Israel
7/7 memorial defaced on anniversary of 2005 attacks with ‘Blair lied thousands died’ graffiti
Australia facing international condemnation after turning around Sri Lankans at sea
Even when it brutalises one of its own teenage citizens, America is helpless against Israel
Socialist Worker called to apologise over ‘vile’ article saying Eton schoolboy Horatio Chapple's death is ‘reason to save the polar bears’
£40000 - £45000 per annum + Benefits + Bonus: Harrington Starr: Web Developer ...
£50000 - £67000 per annum + Benefits + Bonus: Harrington Starr: C# R&D .NE...
£40000 - £50000 per annum + Benefits + Bonus: Harrington Starr: C# Developer (...
£55000 - £65000 per annum + Benefits + Bonus: Harrington Starr: C# Developer (...